Diabetes
Showing NaN - NaN of 60
Diabetes, Type 2 Diabetes Trial in Worldwide (LY3209590, Insulin Degludec)
Recruiting
- Diabetes
- Type 2 Diabetes
- LY3209590
- Insulin Degludec
-
Escondido, California
- +128 more
Jan 18, 2023
Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, empagliflozin)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
-
Tuscumbia, Alabama
- +105 more
Jul 11, 2022
Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, liraglutide, )
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- semaglutide
- +2 more
-
Birmingham, Alabama
- +107 more
Jul 11, 2022
Diabetes, Diabetes, Type 2 Trial in Worldwide (Insulin degludec, Insulin glargine)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- Insulin degludec
- Insulin glargine
-
Anniston, Alabama
- +228 more
Jan 6, 2022
Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, , metformin)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- liraglutide
- +2 more
-
Birmingham, Alabama
- +184 more
Jul 1, 2021
Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, oral )
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- semaglutide
- oral placebo
-
Tucson, Arizona
- +102 more
Jan 14, 2021
Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, )
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- liraglutide
- placebo
-
Birmingham, Alabama
- +81 more
Oct 26, 2020
Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, alpha-glucosidase inhibitors, DPP-4 inhibitors)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- liraglutide
- +6 more
-
Birmingham, Alabama
- +231 more
Jun 16, 2020
Stroke, Myocardial Infarction, Diabetes Trial in Worldwide (pioglitazone, )
Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, )
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- semaglutide
- placebo
-
Tuscumbia, Alabama
- +116 more
Feb 14, 2020
Acute Ischemic Stroke, Diabetes, Hyperglycemia Trial in United States (IV insulin to maintain target glucose concentration of
Completed
- Acute Ischemic Stroke
- +2 more
- IV insulin to maintain target glucose concentration of 80-130 mg/dL
- Standard Care control - sliding scale insulin to keep glucose less than 180 mg/dL
-
Tucson, Arizona
- +69 more
Dec 13, 2019
Diabetes, Diabetes, Type 2 Trial in Worldwide (Insulin degludec/insulin aspart, Insulin glargine, Insulin aspart)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- Insulin degludec/insulin aspart
- +2 more
-
Glendale, Arizona
- +70 more
Nov 8, 2019
Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec, insulin glargine)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- insulin degludec
- insulin glargine
-
Birmingham, Alabama
- +445 more
Jul 10, 2019
Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, )
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- semaglutide
- placebo
-
Birmingham, Alabama
- +252 more
Jun 20, 2019
Diabetes, Diabetes, Type 1 Trial in Worldwide (insulin degludec, insulin detemir, insulin aspart)
Completed
- Diabetes
- Diabetes Mellitus, Type 1
- insulin degludec
- +2 more
-
Little Rock, Arkansas
- +80 more
Jun 3, 2019
Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, exenatide)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
-
Anniston, Alabama
- +145 more
May 28, 2019
Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, insulin glargine)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- semaglutide
- insulin glargine
-
Birmingham, Alabama
- +230 more
May 28, 2019
Diabetes, Diabetes, Type 1 Trial in Worldwide (Faster-acting insulin aspart, insulin detemir, insulin aspart)
Completed
- Diabetes
- Diabetes Mellitus, Type 1
- Faster-acting insulin aspart
- +2 more
-
Mobile, Alabama
- +190 more
May 28, 2019
Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, )
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- semaglutide
- placebo
-
Anniston, Alabama
- +85 more
May 28, 2019
Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, )
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- semaglutide
- placebo
-
Phoenix, Arizona
- +98 more
May 28, 2019
Diabetes, Diabetes, Type 1 Trial in Worldwide (insulin degludec/insulin aspart, insulin aspart, insulin detemir)
Completed
- Diabetes
- Diabetes Mellitus, Type 1
- insulin degludec/insulin aspart
- +2 more
-
Phoenix, Arizona
- +72 more
Jun 3, 2019
Diabetes, Diabetes, Type 1 Trial in Worldwide (Faster-acting insulin aspart, insulin aspart, insulin degludec)
Completed
- Diabetes
- Diabetes Mellitus, Type 1
- Faster-acting insulin aspart
- +2 more
-
Phoenix, Arizona
- +154 more
May 22, 2019
Atherosclerotic Cardiovascular Disease, Familial Hypercholesterolemia, Diabetes Trial in Worldwide (ALN-PCSSC, Normal Saline)
Completed
- Atherosclerotic Cardiovascular Disease
- +2 more
- ALN-PCSSC
- Normal Saline
-
Jacksonville, Florida
- +53 more
Apr 23, 2019